Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Apraglutide and N-acetylcysteine (NAC) show promise in reducing cytarabine's harmful effects on organs.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

New compounds were developed that promote hair growth in mice.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Scientists in India found a safer and efficient way to make a type of medicine called hydantoins from carbamates, which also worked well in making the seizure medicine, Ethotoin.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Metformin may help treat neuroendocrine tumors.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Some dibenzo compounds might help treat cancer with fewer side effects.

The treatment is safe and shows promise for metastatic breast cancer.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

The research created new azasteroids and pseudoazulenyl nitrones, which could be useful in medicine.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Anti-cancer drugs are diverse and hard to classify due to their different forms and actions.

Some HIV treatments can harm mitochondria, potentially causing side effects like lactic acidosis and nerve damage.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

A new compound effectively inhibits human 5α-reductase 1.

The compound 4c showed strong potential as an anticancer agent.

A new method efficiently modifies alkenes to create useful medicinal compounds.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Baricitinib is safer than methotrexate for treating severe alopecia areata.